US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist

17.160
-0.170-0.98%

Close Dec 13 16:00 ET

17.160
0.0000.00%

Post 20:01 ET

251.32MMarket Cap-2.58P/E (TTM)

Anika Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-6.54%38.75M

-5.37%41.92M

6.85%40.52M

6.67%166.66M

8.45%42.97M

2.98%41.47M

11.71%44.3M

3.35%37.92M

5.71%156.24M

10.61%39.62M

Operating revenue

-6.54%38.75M

-5.37%41.92M

6.85%40.52M

6.67%166.66M

8.45%42.97M

2.98%41.47M

11.71%44.3M

3.35%37.92M

5.71%156.24M

10.61%39.62M

Cost of revenue

125.85%37.31M

-5.05%14.56M

5.40%15.9M

1.46%63.57M

7.43%16.64M

-5.51%16.52M

3.62%15.33M

1.29%15.08M

-3.38%62.66M

-12.42%15.49M

Gross profit

-94.23%1.44M

-5.55%27.37M

7.81%24.63M

10.16%103.09M

9.11%26.33M

9.50%24.94M

16.53%28.97M

4.77%22.84M

12.82%93.58M

33.07%24.13M

Operating expense

-19.20%26.36M

-16.56%27.2M

-16.12%29.69M

13.77%128.54M

-9.34%27.92M

14.14%32.62M

15.44%32.6M

39.59%35.4M

11.39%112.98M

16.52%30.8M

Selling and administrative expenses

-23.02%19.11M

-16.39%19.81M

-20.26%21.53M

13.04%95.85M

-11.77%20.34M

16.69%24.83M

11.38%23.69M

40.60%27M

14.44%84.79M

12.81%23.05M

Research and development costs

-7.02%7.24M

-17.01%7.4M

-2.81%8.16M

16.00%32.69M

-2.12%7.59M

6.71%7.79M

27.80%8.91M

36.43%8.4M

3.13%28.18M

29.15%7.75M

Operating profit

-224.68%-24.92M

104.43%161K

59.67%-5.06M

-31.18%-25.45M

76.14%-1.59M

-32.36%-7.67M

-7.39%-3.63M

-253.21%-12.55M

-4.98%-19.4M

19.66%-6.67M

Net non-operating interest income expense

-36.06%406K

6.06%595K

9.83%592K

253.52%2.31M

109.06%577K

45.64%635K

484.38%561K

450.00%539K

447.87%654K

687.23%276K

Non-operating interest income

-36.06%406K

----

--635K

----

Total other finance cost

----

-6.06%-595K

-9.83%-592K

-253.52%-2.31M

----

-484.38%-561K

-450.00%-539K

-447.87%-654K

-687.23%-276K

Other net income (expense)

-3.1M

-62.19M

Special income (charges)

---3.1M

----

---62.19M

--0

----

--0

----

-Less：Restructuring and merger&acquisition

----

--0

----

--0

----

-Less:Impairment of capital assets

--3.1M

----

--62.19M

--0

----

--0

----

Income before tax

-292.26%-27.61M

124.63%756K

62.79%-4.47M

-355.17%-85.33M

-888.95%-63.2M

-31.28%-7.04M

6.54%-3.07M

-224.00%-12.01M

-872.39%-18.75M

30.31%-6.39M

Income tax

598.27%2.31M

356.53%844K

102.58%43K

31.57%-2.66M

86.24%-204K

60.99%-463K

25.57%-329K

-114.71%-1.66M

-127.71%-3.89M

56.09%-1.48M

Net income

-354.96%-29.92M

96.79%-88K

56.39%-4.51M

-456.34%-82.67M

-1,183.62%-63M

-57.51%-6.58M

3.59%-2.74M

-252.88%-10.35M

-459.43%-14.86M

15.28%-4.91M

Net income continuous Operations

-354.96%-29.92M

96.79%-88K

56.39%-4.51M

-456.34%-82.67M

-1,183.62%-63M

-57.51%-6.58M

3.59%-2.74M

-252.88%-10.35M

-459.43%-14.86M

15.28%-4.91M

Minority interest income

Net income attributable to the parent company

-354.96%-29.92M

96.79%-88K

56.39%-4.51M

-456.34%-82.67M

-1,183.62%-63M

-57.51%-6.58M

3.59%-2.74M

-252.88%-10.35M

-459.43%-14.86M

15.28%-4.91M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-354.96%-29.92M

96.79%-88K

56.39%-4.51M

-456.34%-82.67M

-1,183.62%-63M

-57.51%-6.58M

3.59%-2.74M

-252.88%-10.35M

-459.43%-14.86M

15.28%-4.91M

Basic earnings per share

-351.11%-2.03

94.74%-0.01

56.34%-0.31

-452.94%-5.64

-1,164.71%-4.3

-55.17%-0.45

5.00%-0.19

-255.00%-0.71

-451.72%-1.02

15.00%-0.34

Diluted earnings per share

-351.11%-2.03

94.74%-0.01

56.34%-0.31

-452.94%-5.64

-1,164.71%-4.3

-55.17%-0.45

5.00%-0.19

-255.00%-0.71

-464.29%-1.02

15.00%-0.34

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-6.54%38.75M	-5.37%41.92M	6.85%40.52M	6.67%166.66M	8.45%42.97M	2.98%41.47M	11.71%44.3M	3.35%37.92M	5.71%156.24M	10.61%39.62M
Operating revenue	-6.54%38.75M	-5.37%41.92M	6.85%40.52M	6.67%166.66M	8.45%42.97M	2.98%41.47M	11.71%44.3M	3.35%37.92M	5.71%156.24M	10.61%39.62M
Cost of revenue	125.85%37.31M	-5.05%14.56M	5.40%15.9M	1.46%63.57M	7.43%16.64M	-5.51%16.52M	3.62%15.33M	1.29%15.08M	-3.38%62.66M	-12.42%15.49M
Gross profit	-94.23%1.44M	-5.55%27.37M	7.81%24.63M	10.16%103.09M	9.11%26.33M	9.50%24.94M	16.53%28.97M	4.77%22.84M	12.82%93.58M	33.07%24.13M
Operating expense	-19.20%26.36M	-16.56%27.2M	-16.12%29.69M	13.77%128.54M	-9.34%27.92M	14.14%32.62M	15.44%32.6M	39.59%35.4M	11.39%112.98M	16.52%30.8M
Selling and administrative expenses	-23.02%19.11M	-16.39%19.81M	-20.26%21.53M	13.04%95.85M	-11.77%20.34M	16.69%24.83M	11.38%23.69M	40.60%27M	14.44%84.79M	12.81%23.05M
Research and development costs	-7.02%7.24M	-17.01%7.4M	-2.81%8.16M	16.00%32.69M	-2.12%7.59M	6.71%7.79M	27.80%8.91M	36.43%8.4M	3.13%28.18M	29.15%7.75M
Operating profit	-224.68%-24.92M	104.43%161K	59.67%-5.06M	-31.18%-25.45M	76.14%-1.59M	-32.36%-7.67M	-7.39%-3.63M	-253.21%-12.55M	-4.98%-19.4M	19.66%-6.67M
Net non-operating interest income expense	-36.06%406K	6.06%595K	9.83%592K	253.52%2.31M	109.06%577K	45.64%635K	484.38%561K	450.00%539K	447.87%654K	687.23%276K
Non-operating interest income	-36.06%406K	----	----	----	----	--635K	----	----	----	----
Total other finance cost	----	-6.06%-595K	-9.83%-592K	-253.52%-2.31M	----	----	-484.38%-561K	-450.00%-539K	-447.87%-654K	-687.23%-276K
Other net income (expense)	-3.1M			-62.19M
Special income (charges)	---3.1M	----	----	---62.19M	---62.19M	--0	----	----	--0	----
-Less：Restructuring and merger&acquisition	----	----	----	--0	----	----	----	----	--0	----
-Less:Impairment of capital assets	--3.1M	----	----	--62.19M	--62.19M	--0	----	----	--0	----
Income before tax	-292.26%-27.61M	124.63%756K	62.79%-4.47M	-355.17%-85.33M	-888.95%-63.2M	-31.28%-7.04M	6.54%-3.07M	-224.00%-12.01M	-872.39%-18.75M	30.31%-6.39M
Income tax	598.27%2.31M	356.53%844K	102.58%43K	31.57%-2.66M	86.24%-204K	60.99%-463K	25.57%-329K	-114.71%-1.66M	-127.71%-3.89M	56.09%-1.48M
Net income	-354.96%-29.92M	96.79%-88K	56.39%-4.51M	-456.34%-82.67M	-1,183.62%-63M	-57.51%-6.58M	3.59%-2.74M	-252.88%-10.35M	-459.43%-14.86M	15.28%-4.91M
Net income continuous Operations	-354.96%-29.92M	96.79%-88K	56.39%-4.51M	-456.34%-82.67M	-1,183.62%-63M	-57.51%-6.58M	3.59%-2.74M	-252.88%-10.35M	-459.43%-14.86M	15.28%-4.91M
Minority interest income
Net income attributable to the parent company	-354.96%-29.92M	96.79%-88K	56.39%-4.51M	-456.34%-82.67M	-1,183.62%-63M	-57.51%-6.58M	3.59%-2.74M	-252.88%-10.35M	-459.43%-14.86M	15.28%-4.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-354.96%-29.92M	96.79%-88K	56.39%-4.51M	-456.34%-82.67M	-1,183.62%-63M	-57.51%-6.58M	3.59%-2.74M	-252.88%-10.35M	-459.43%-14.86M	15.28%-4.91M
Basic earnings per share	-351.11%-2.03	94.74%-0.01	56.34%-0.31	-452.94%-5.64	-1,164.71%-4.3	-55.17%-0.45	5.00%-0.19	-255.00%-0.71	-451.72%-1.02	15.00%-0.34
Diluted earnings per share	-351.11%-2.03	94.74%-0.01	56.34%-0.31	-452.94%-5.64	-1,164.71%-4.3	-55.17%-0.45	5.00%-0.19	-255.00%-0.71	-464.29%-1.02	15.00%-0.34
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Heat List

Overall

No Data